Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin.

door Neu, H C, Meropol, N J, Fu, K P
Gepubliceerd in 1981

Patient–physician discordance in goals of care for patients with advanced cancer

door Douglas, S.L., Daly, B.J., Meropol, N.J., Lipson, A.R.
Gepubliceerd in Curr Oncol (2019)

Constructs of burden of illness in older patients with breast cancer: a comparison of measurement methods.

door Mandelblatt, J S, Bierman, A S, Gold, K, Zhang, Y, Ng, J H, Maserejan, N, Hwang, Y T, Meropol, N J, Hadley, J, Silliman, R A
Gepubliceerd in 2001

Relationship of increased aurora kinase A gene copy number, prognosis and response to chemotherapy in patients with metastatic colorectal cancer

door Dotan, E, Meropol, N J, Zhu, F, Zambito, F, Bove, B, Cai, K Q, Godwin, A K, Golemis, E A, Astsaturov, I, Cohen, S J
Gepubliceerd in 2012

Phase I study of capecitabine combined with radioembolization using yttrium-90 resin microspheres (SIR-Spheres) in patients with advanced cancer

door Cohen, S J, Konski, A A, Putnam, S, Ball, D S, Meyer, J E, Yu, J Q, Astsaturov, I, Marlow, C, Dickens, A, Cade, D N, Meropol, N J
Gepubliceerd in 2014

Circulating cytokines and monocyte subpopulations as biomarkers of outcome and biological activity in sunitinib-treated patients with advanced neuroendocrine tumours

door Zurita, A J, Khajavi, M, Wu, H-K, Tye, L, Huang, X, Kulke, M H, Lenz, H-J, Meropol, N J, Carley, W, DePrimo, S E, Lin, E, Wang, X, Harmon, C S, Heymach, J V
Gepubliceerd in Br J Cancer (2015)

Attitudinal barriers to participation in oncology clinical trials: factor analysis and correlates of barriers

door MANNE, S., KASHY, D., ALBRECHT, T., WONG, Y.-N., FLAMM, A. LEDERMAN, BENSON, A. B., MILLER, S.M., FLEISHER, LINDA, BUZAGLO, J., ROACH, N., KATZ, M., ROSS, E., COLLINS, M., POOLE, D., RAIVITCH, S., MILLER, D.M., KINZY, T.G., LIU, T., MEROPOL, N.J.
Gepubliceerd in Eur J Cancer Care (Engl) (2014)